Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2018, Article ID 5812704, 5 pages
https://doi.org/10.1155/2018/5812704
Research Article

Plasma Chemerin Levels Are Increased in ST Elevation Myocardial Infarction Patients with High Thrombus Burden

1Department of Cardiology, Samsun Training and Research Hospital, University of Health Sciences, Samsun, Turkey
2Department of Microbiology, Gazi State Hospital, Samsun, Turkey
3Department of Cardiology, Ahi Evren Training and Research Hospital, University of Health Sciences, Trabzon, Turkey

Correspondence should be addressed to Uğur Arslan; moc.oohay@5nalsrarugu

Received 19 October 2017; Accepted 6 February 2018; Published 26 March 2018

Academic Editor: Anne Knowlton

Copyright © 2018 Ahmet Hakan Ateş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Scherer, “Adipose tissue: from lipid storage compartment to endocrine organ,” Diabetes, vol. 55, no. 6, pp. 1537–1545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Ahima and J. S. Flier, “Adipose tissue as an endocrine organ,” Trends in Endocrinology and Metabolism, vol. 11, no. 8, pp. 327–332, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Trayhurn and I. S. Wood, “Adipokines: inflammation and the pleiotropic role of white adipose tissue,” British Journal of Nutrition, vol. 92, no. 3, pp. 347–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. B. B. Kahn and J. S. Flier, “Obesity and insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 473–481, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nagpal, S. Patel, H. Jacobe et al., “Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin,” Journal of Investigative Dermatology, vol. 109, no. 1, pp. 91–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Roman, S. D. Parlee, and C. J. Sinal, “Chemerin: a potential endocrine link between obesity and type 2 diabetes,” Endocrine, vol. 42, no. 2, pp. 243–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Kutzleb, A. Busmann, M. Wendland, and E. Maronde, “Discovery of novel regulatory peptides by reverse pharmacology; spotlight on chemerin and the RF-amide peptides metastin and QRFP,” Current Protein and Peptide Science, vol. 6, no. 3, pp. 265–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. B. Goralski, T. C. McCarthy, E. A. Hanniman et al., “Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism,” Journal of Biological Chemistry, vol. 282, no. 38, pp. 28175–28188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, and D. Communi, “Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity,” Journal of Immunology, vol. 175, no. 1, pp. 487–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Weigert, M. Neumeier, J. Wanninger et al., “Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes,” Clinical Endocrinology, vol. 72, no. 3, pp. 342–348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Lehrke, A. Becker, M. Greif et al., “Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis,” European Journal of Endocrinology, vol. 161, no. 2, pp. 339–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Inci, G. Aksan, and P. Dogan, “Chemerin as an independent predictor of cardiovascular event risk,” Therapeutic Advances in Endocrinology and Metabolism, vol. 7, no. 2, pp. 57–68, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. S. G. Spiroglou, C. G. Kostopoulos, J. N. Varakis, and H. H. Papadaki, “Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis,” Journal of Atherosclerosis and Thrombosis, vol. 17, no. 2, pp. 115–130, 2010. View at Publisher · View at Google Scholar
  14. G. G. Gensini, “A more meaningful scoring system for determining the severity of coronary heart disease,” American Journal of Cardiology, vol. 51, no. 3, p. 606, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Sianos, M. I. Papafaklis, and P. W. Serruys, “Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention,” Journal of Invasive Cardiology, vol. 22, no. 10, pp. 6B–14B, 2010. View at Google Scholar
  16. O. Topaz, “Comparison between thrombus removal devices: aspirations meet reality,” Catheterization and Cardiovascular Interventions, vol. 78, no. 1, pp. 20–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Gibson, J. A. de Lemos, S. A. Murphy et al., “Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy,” Circulation, vol. 103, no. 21, pp. 2550–2554, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Tedgui and Z. Mallat, “Cytokines in atherosclerosis: pathogenic and regulatory pathways,” Physiological Reviews, vol. 86, no. 2, pp. 515–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Wan, X. Cui, J. Shao et al., “Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression,” Cell Stress and Chaperones, vol. 19, no. 5, pp. 715–724, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. E. Alam, S. S. Nasser, K. E. Fernainy, A. A. Habib, and K. F. Badr, “Cytokine imbalance in acute coronary syndrome,” Current Opinion in Pharmacology, vol. 4, no. 2, pp. 166–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Huang, Y. W. Wu, C. C. Wu et al., “Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease,” Cardiovascular Diabetology, vol. 12, no. 1, p. 105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Nakamura, K. Shimada, D. Fukuda et al., “Implications of plasma concentrations of adiponectin in patients with coronary artery disease,” Heart, vol. 90, no. 5, pp. 528–533, 2004. View at Publisher · View at Google Scholar
  23. T. Pischon, C. M. Bamberger, J. Kratzsch et al., “Association of plasma resistin levels with coronary heart disease in women,” Obesity Research, vol. 13, no. 10, pp. 1764–1771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. J. Yoo, H. Y. Choi, S. J. Yang et al., “Circulating chemerin level is independently correlated with arterial stiffness,” Journal of Atherosclerosis and Thrombosis, vol. 19, no. 1, pp. 59–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Aydin, U. Canpolat, S. Akin et al., “Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes,” Anatolian Journal of Cardiology, vol. 16, pp. 749–755, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Trepels, A. M. Zeiher, and S. Fichtlscherer, “Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification,” Herz, vol. 29, no. 8, pp. 769–776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Niccoli, A. Menozzi, D. Capodanno et al., “Relationship between serum inflammatory biomarkers and thrombus characteristics in patients with ST segment elevation myocardial infarction,” Cardiology, vol. 137, no. 1, pp. 27–35, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. T. F. Luscher and M. Barton, “Biology of the endothelium,” Clinical Cardiology, vol. 20, no. 11, p. II-3-10, 1997. View at Google Scholar
  29. A. Sjoholm and T. Nystrom, “Endothelial inflammation in insulin resistance,” The Lancet, vol. 365, no. 9459, pp. 610–612, 2005. View at Publisher · View at Google Scholar